Welcome to our dedicated page for Caring Brands SEC filings (Ticker: CBRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Caring Brands's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Caring Brands's regulatory disclosures and financial reporting.
Caring Brands, Inc. (CBRA) filed an amendment to its S-1 registration describing a planned offering and company history. As of September 5, 2025 the company had 13,736,925 shares of common stock issued and outstanding. The prospectus shows a public offering price implied at $4.00 per share with an underwriting discount of $0.32 per share and proceeds to the company of $3.68 per share, totaling proceeds of $3,680,000 (with related underwriting fees of $320,000). The filing discloses outstanding warrants to purchase up to 2,110,000 shares at $3.00 (expiring May 1, 2027) and 200,000 warrants at $4.00 (expiring August 6, 2030).
The company acquired Photocil assets in June 2022 after obtaining an exclusive license in July 2021, launched the product in India in September 2022 (OTC) and entered the U.S. market in Q4 2022 but removed it from the U.S. market in early/mid 2023 because of insufficient sales. The filing states plans to apply for an NDC for FDA registration prior to a U.S. relaunch. Clinical trial publications and a reported p-value 0.03 are referenced.
Caring Brands, Inc. (CBRA) amended its S-1 registration to detail an offering and provide updated corporate and financial information. The company reports 13,736,925 shares of common stock outstanding as of September 5, 2025, and discloses outstanding warrants to purchase up to 2,110,000 shares at $3.00 (expiring May 1, 2027) and 200,000 warrants at $4.00 (expiring August 6, 2030). The prospectus shows an underwriting discount of $0.32 per share and proceeds to the company of $3.68 per share, with aggregate proceeds before expenses shown as $3,680,000. Financial excerpts show operating losses, limited revenue and cash activity, including an increase (decrease) in cash of $(395,105) and $305,284 in comparative periods. The filing describes the Photocil asset acquisition and exclusive license history, past U.S. commercialization and removal from the U.S. market due to insufficient sales, and plans to seek an NDC for a U.S. relaunch. Corporate governance, board composition, committees, related party transaction disclosure and disclosure of potential licensing discussions in Europe and South America are included.
FAQ
What is the current stock price of Caring Brands (CBRA)?
